Khiron Life Sciences (Khiron Life Sciences) Capex-to-Operating-Income : 0.00 (As of Sep. 2022)

View and export this data going back to 2018. Start your Free Trial

What is Khiron Life Sciences Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Khiron Life Sciences's Capital Expenditure for the three months ended in Sep. 2022 was $-0.65 Mil. Its Operating Income for the three months ended in Sep. 2022 was $-2.63 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.

Khiron Life Sciences Capex-to-Operating-Income Historical Data

The historical data trend for Khiron Life Sciences's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Khiron Life Sciences Capex-to-Operating-Income Chart

Khiron Life Sciences Annual Data

Trend

May12

May13

May14

May15

May16

May17

Dec18

Dec19

Dec20

Dec21

Capex-to-Operating-Income

Get a 7-Day Free Trial

Khiron Life Sciences Quarterly Data
	Nov17	Feb18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Capex-to-Operating-Income	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Khiron Life Sciences's Capex-to-Operating-Income

For the Drug Manufacturers - Specialty & Generic subindustry, Khiron Life Sciences's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Khiron Life Sciences's Capex-to-Operating-Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Khiron Life Sciences's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Khiron Life Sciences's Capex-to-Operating-Income falls into.

Khiron Life Sciences Capex-to-Operating-Income Calculation

Khiron Life Sciences's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2021 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (-1.363)	/	-15.459
	=	N/A

Khiron Life Sciences's Capex-to-Operating-Income for the quarter that ended in Sep. 2022 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (-0.654)	/	-2.627
	=	N/A

Khiron Life Sciences (OTCPK:KHRNF) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.

Khiron Life Sciences Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Khiron Life Sciences's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Khiron Life Sciences (Khiron Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Khiron Life Sciences Corp (OTCPK:KHRNF) » Definitions » Capex-to-Operating-Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

2300 - 500 Burrard Street, Vancouver, BC, CAN, V6C 2B5

Website

https://www.khiron.ca

Khiron Life Sciences Corp is a vertically integrated medical company with core operations in Latin America and Europe, The company's platform leverages medical health clinics and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific, product innovation, and cannabis operations expertise to drive prescriptions and brand loyalty with patients worldwide. The company has a presence in Mexico, Peru, Germany, the United Kingdom, and Brazil.